NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 8 - Malignant disease and immunosuppression 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

08.02.04 Other immunomodulating drugs
08.02.04 Interferon Alfa
08.02.04 Interferon beta

Interferon Beta (Avonex®)

RED
Formulary

For exisiting patients on hoemcare only

Not for new patients

Interferon Beta (Rebif®)

RED
Formulary

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

Restricted - prescribing by Consultant Neurologists and clinical nurse specialists (MS)

Interferon Beta 300mcg (Betaferon®)
(Subcutaneous injection)

RED
Formulary

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.
Restricted - prescribing by Consultant Neurologists and clinical nurse specialists (MS).

08.02.04 Aldesleukin
08.02.04 Glatiramer acetate
08.02.04 Natalizumab
Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.